Your AI Tools Inherited Every Permission Your Staff Already Had. Most Organizations Haven’t Noticed.
Shadow AI adoption is moving faster than the governance frameworks meant to contain it, and in healthcare, that gap has direct compliance consequences.
Generative AI tools have moved into healthcare operations faster than almost any technology before them drafting clinical notes, summarizing patient communications, assisting with billing queries, and supporting administrative workflows. Much of this adoption happened organically, tool by tool, team by team, often without formal review by IT, security, or compliance functions.
This creates a specific and underappreciated risk: AI tools typically inherit the access permissions of the person or system using them. An AI assistant connected to an email account, a scheduling system, or an EHR-adjacent tool doesn’t get a reduced, purpose-built level of access. It gets whatever the underlying account already has, often broader than the AI task actually requires.
The governance gap
The core problem isn’t that healthcare organizations are using AI. It’s that adoption has outpaced governance. Most organizations can name the major systems in their environment, their EHR, their billing platform, their email provider. Far fewer can produce a complete inventory of every AI tool currently in use across departments, what data each tool can access, and whether that access has ever been formally reviewed.
This matters under HIPAA specifically because access to ePHI doesn’t stop being a regulated event just because the access point is an AI tool rather than a person. If an AI assistant can read, summarize, or process protected health information, that tool is functionally a business associate. and most organizations have not extended their BAA and risk assessment processes to cover it.
Why this is a board-level issue, not just an IT issue
The financial and reputational exposure here isn’t hypothetical. A single ungoverned AI integration with broad data access represents the same breach risk as an ungoverned vendor relationship, except it’s often invisible to leadership until an incident forces visibility. The risk isn’t that AI is being used. It’s that it’s being used without the same scrutiny applied to every other system touching protected data.
Building governance that doesn’t slow the organization down
- Inventory every AI tool currently in use, including ones adopted informally by individual teams, not just centrally procured platforms.
- Apply least-privilege access to every AI integration. Tools should access only what their specific function requires, not the full permission set of the connected account.
- Extend your BAA and risk assessment process to cover AI vendors the same way it covers any other entity touching ePHI.
The organizations getting this right aren’t the ones banning AI. They’re the ones governing it with the same rigor applied to every other system that touches patient data, before an incident makes that governance mandatory.